We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma (RAD001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00933374
Recruitment Status : Terminated (delayed recruitment)
First Posted : July 7, 2009
Last Update Posted : March 18, 2015
Sponsor:
Information provided by (Responsible Party):
Heinrich-Heine University, Duesseldorf

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2013
  Study Completion Date : September 2013